info iconCurrently, the share price for Beta Drugs Ltd. is delayed.

close icon
Beta Drugs Ltd. Logo

Beta Drugs Ltd.

₹2,199.45
NSE
--   ( -- %) 1D



Income Statement

Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
Created with Highcharts 7.2.2RevenueNet IncomeProfit Margin080.0160.0240.0320.06%8%10%12%14%
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Particulars (In Cr)Mar 2024Y/Y Change
Operating Revenue295.71+30.21%
Other Income1.36+81.33%
Total Income297.07+30.37%
Total Expenditure248.32+32.93%
EBIDT61.36+13.88%
Depreciation9.78-6.05%
Interest2.82+17.01%
Tax12.32+19.15%
Net Profit36.44+18.62%

Balance Sheet

A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Created with Highcharts 7.2.2Total AssetsTotal LiabilitiesTotal Debt to Equity080.0160.0240.0320.00%16%32%48%64%
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Particulars (In Cr)Mar 2024Y/Y Change
Total Current Assets177.87+39.31%
Total Non-Current Assets76.23+7.76%
Fixed assets64.59+2.92%
Total assets254.10+28.06%
Total Current Liabilities84.67+34.35%
Total Non-Current Liabilities12.31-1.68%
Total Capital Plus Liabilities254.10+28.06%
Total Shareholder Funds157.12+27.86%
Total Debt to Equity0.07-46.15%

Cash Flow

The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Created with Highcharts 7.2.2OperatingInvestingFinancing-60.0-30.0030.060.0
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Particulars (In Cr)Mar 2024Y/Y Change
Cash from Operating Activity30.93+32.29%
Cash from Financing Activities-7.49+203.24%
Cash from Investing Activities-13.97-26.74%
Net Cash Flow9.47+414.67%

Shareholding Pattern

It represents how the shares of a company are distributed among different shareholding entities such as FIIs (Foreign Institutional Investors), DIIs (Domestic Institutional Investors), Promoters, Retail Investors, etc. A change in their holdings can indicate performance outlook for the stock.
Created with Highcharts 7.2.2PromoterDIIFIIPublic
66.7% (0.00%)
0.2% (0.10%)
1.2% (0.30%)
32% (-0.20%)
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer